 Connection
Hitoshi Irabu to Interleukin-6
This is a "connection" page, showing publications Hitoshi Irabu has written about Interleukin-6.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.191 |
|
|
|
-
Sakumura N, Irabu H, Inoue N, Mizuta M, Shimizu M. Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab. Rheumatology (Oxford). 2020 01 01; 59(1):252-254.
Score: 0.114
-
Hayashi Y, Hatano M, Kaneko S, Shimbo A, Irabu H, Mori M, Shimizu M. Macrophage activation syndrome associated with neonatal lupus erythematosus. Lupus. 2025 Aug; 34(9):978-981.
Score: 0.041
-
Kaneko S, Shimizu M, Shimbo A, Irabu H, Yokoyama K, Furuno K, Tanaka T, Ueno K, Fujita S, Iwata N, Fujimura J, Akamine K, Mizuta M, Nakagishi Y, Minato T, Watanabe K, Kobayashi A, Endo T, Tabata K, Mori M, Morio T. Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers. Cytokine. 2023 09; 169:156280.
Score: 0.036
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|